We, at Plasma 55 GmbH, are thrilled to be a part of the esteemed Biotexin Group and to introduce our role in the vital mission of addressing the plasma shortage in Europe. Established in 2023 as the newest division, we are a testament to the continuous growth and innovation that has characterized Biotexin since its inception in 2018.
"EUROPE NEEDS MORE PLASMA" is not just a message but a call to action that we at Plasma 55 GmbH take to heart. We are more than a company; we are a bridge between the selfless donors and the patients who are in dire need of plasma.
Plasma, a crucial element that constitutes 55% of our blood, is indispensable for treating patients with severe burns, blood diseases, and weakened immune systems. Despite its importance, there is an alarming shortage of over 5 million liters in the EU for the production of Plasma Derived Medicinal Products (PDMPs).
At Plasma 55 GmbH, we are committed to addressing this shortage. We take pride in establishing, collecting, and delivering human plasma in Germany. Every drop we collect is a step closer to a world where no patient has to suffer due to a lack of plasma.
We are not just an extension of the Biotexin Group but also a pivotal part of their vision to enhance the lives of patients through innovative solutions and services. Together, we are strong, and together, we will ensure that Europe receives the plasma it so desperately needs.
At Plasma55, we understand the critical importance of plasma-derived therapies in treating various medical conditions, from immune deficiencies to bleeding disorders.
With a steadfast commitment to excellence, we aim to play a crucial role in the European healthcare ecosystem by collecting life-saving blood plasma from healthy, willing donors.
Our mission is to save lives and improve patient outcomes by providing a reliable and safe supply of high-quality plasma for the production of life-saving therapies. We are committed to ensuring the well-being of our donors, maintaining the highest standards of safety and quality, and fostering strong partnerships with healthcare providers and the community to meet the critical need for plasma-derived medicines.
To be a leading provider of life-saving plasma, driving advancements in
the donor experience and positively impacting the lives of patients
across Europe. We envision a future where accessible and safe
plasma-derived therapies transform the landscape of medical treatment,
empowering individuals to lead healthier and fuller lives.
